Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AMN HEALTHCARE SERVICES, INC.

(AMN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AMN Healthcare Services, Inc. : No turn-around in sight

07/30/2021 | 02:35am EDT
long trade
Live
Entry price : 99.83$ | Target : 120$ | Stop-loss : 86$ | Potential : 20.2%
Shares in AMN Healthcare Services, Inc. show a positive technical chart pattern over the medium term, which suggests that the rising trend should be followed.
Investors have an opportunity to buy the stock and target the $ 120.
AMN Healthcare Services, Inc. : AMN Healthcare Services, Inc. : No turn-around in sight
Summary
  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.
  • The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.

Weaknesses
  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • With a 2021 P/E ratio at 23.63 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart
Subsector Other Healthcare Facilities & Services
1st jan.Capitalization (M$)Investor Rating
AMN HEALTHCARE SERVICES, IN..63.24%5 383
CVS HEALTH CORPORATION25.42%113 140
HCA HEALTHCARE, INC.53.11%81 812
LABORATORY CORPORATION OF A..39.04%28 114
REDE D'OR SÃO LUIZ S.A.-2.36%24 906
FRESENIUS MEDICAL CARE AG &..-11.00%20 974
QUEST DIAGNOSTICS INCORPORA..22.56%18 312
DR. SULAIMAN AL HABIB MEDIC..58.90%16 291
DAVITA INC.3.43%12 647
UNIVERSAL HEALTH SERVICES, ..4.47%12 024
OAK STREET HEALTH, INC.-24.48%11 359
More Results

ę MarketScreener.com 2021

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (USD)
Sales 2021 3 279 M - -
Net income 2021 234 M - -
Net Debt 2021 686 M - -
P/E ratio 2021 23,4x
Yield 2021 -
Capitalization 5 266 M 5 266 M -
EV / Sales 2021 1,82x
EV / Sales 2022 1,93x
Nbr of Employees 3 000
Free-Float 94,0%
Upcoming event on AMN HEALTHCARE SERVICES, INC.
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 111,41 $
Average target price 116,70 $
Spread / Average Target 4,75%
EPS Revisions
Managers and Directors
Susan R. Salka President, Chief Executive Officer & Director
Christopher Schwartz Chief Financial Officer & Controller
Douglas D. Wheat Chairman
Mark J. Hagan Chief Information & Digital Officer
Cole Edmonson Chief Experience & Clinical Officer